Erratum to Current antiplatelet therapy for Japanese patients with ST elevation acute myocardial infarction: J-AMI registry (Cardiovasc Interv and Ther, 10.1007/s12928-012-0146-8);Current antiplatelet therapy for Japanese patients with ST elevation acute myocardial infarction: J-AMI registry

Cardiovascular Intervention and Therapeutics

Volumn 28, Issue 2, 2013, Pages 162-169

  Nakamura, Masato ^a   Yamagishi, Masakazu ^b   Ueno, Takafumi ^c   Hara, Kazuhiro ^d   Ishiwata, Sugao ^e   Itoh, Tomonori ^f   Hamanaka, Ichiro ^g   Wakatsuki, Tetuszo ^h   Sugano, Teruyasu ⁱ   Kawai, Kazuya ^j   Kimura, Takeshi ^k  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c KURUME UNIVERSITY HOSPITAL   (Japan)

^d MITSUI MEMORIAL HOSPITAL   (Japan)

^e TORANOMON HOSPITAL   (Japan)

^f IWATE MEDICAL UNIVERSITY   (Japan)

^g Rakuwakai Marutamachi Hospital   (Japan)

^h UNIVERSITY OF TOKUSHIMA   (Japan)

ⁱ YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^j Chikamori Hospital   (Japan)

^k KYOTO UNIVERSITY   (Japan)

more..

Author keywords

Acute myocardial infarction; Antiplatelet treatment; Bleeding complication; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; TICLOPIDINE;

ACUTE HEART INFARCTION; AGED; ANTICOAGULANT THERAPY; ARTICLE; BARE METAL STENT; BLEEDING; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DISEASE COURSE; DRUG ELUTING STENT; FEMALE; HEART CATHETERIZATION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT OUTCOME;

EID: 84876066379     PISSN: 18684300     EISSN: 18684297     Source Type: Journal    
DOI: 10.1007/s12928-013-0172-1     Document Type: Erratum

References (16)

1. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009; 361: 1045-57.
2. The CURRENT-OASIS 7 Investigators. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med. 2010; 363: 930-42.
3. Montalescot G, Wiviott SD, Braunwald E, et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomized controlled trial. Lancet. 2009; 373: 723-31.
4. Suh JW, Mehran R, Claessen BE, Xu K, Baber U, Dangas G, et al. Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction. The HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol. 2011; 58: 1750-6.
5. Rao SV, O'Grady K, Pieper KS, et al. Impact of bleeding severity on clinical outcomes among patient with acute coronary syndromes. Am J Cardiol. 2005; 96: 1200-6.
6. Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 2006; 114: 774-82.
7. Manoukian SV, Feit F, Mehran R, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial. J Am Coll Cardiol. 2007; 49: 1362-8.
8. GUSTO. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993; 329: 673-82.
9. Mehran R, Pocock S, Nikolsky E, Dangas GD, Clayton T, Claessen BE, et al. Impact of bleeding on mortality after percutaneous coronary intervention: results from a patient-level pooled analysis of the REPLACE-2 (Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events), ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy), and HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trials. J Am Coll Cardiovasc Interv. 2011; 4: 654-64.
10. Mehran R, Lansky AJ, Witzenbichler B, et al. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomized controlled trial. Lancet. 2009; 374: 1149-59.
11. Moscucci M, Fox KAA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: the Global registry of acute coronary events (GRACE). Eur Heart J. 2003; 24: 1815-23.
12. Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangasz GD, Kirtane AJ, et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010; 55: 2556-66.
13. Ndrepepa G, Berger PB, Mehilli J, et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end-point. J Am Coll Cardiol. 2008; 51: 690-7.
14. Stone GW, White HD, Ohman EM, et al. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet. 2007; 369: 907-19.
15. Dangas G, Caixeta A, Mehran R, Parise H, Lansky A, Cristea E, et al. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation. 2011; 123: 1745-56.
16. Dangas G, Mehran R, Guagliumi G, Caixeta A, Witzenbichler B, Aoki J, et al. Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty. Results from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol. 2009; 54: 1438-46.